Sergey Suchkov | Clinical Immunology | Excellence in Innovation Award

Published on by Global Scholar Awards

Prof. Sergey Suchkov | Clinical Immunology | Excellence in Innovation Award

Professor in Medicine and Immunology | N.D. Zelinskii Institute for Organic Chemistry | Russia

Prof. Sergey V. Suchkov, MD, PhD, is a distinguished physician-scientist and international leader in immunology, personalized and precision medicine, and biodesign. Born in Astrakhan, Russia, he graduated with an MD from Astrakhan State Medical University in 1980 and earned his PhD from Sechenov University in 1985, followed by a Doctor’s Degree from the National Institute of Immunology in 2002. His professional experience spans over four decades, including senior research positions at the USSR Academy of Medical Sciences, the Moscow Clinical Research Institute (MONIKI), and leadership roles as Director of the Center for Personalized & Precision Medicine at Sechenov University, Vice-Director of the Institute for Biotech & Global Health at RosBioTech National University, and Director of the Center for Biodesign at N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences. He has contributed to international collaborations, with advanced training and research engagements at the NEI, NIH, USA, Wills Eye Hospital, Philadelphia, and invited work at several British universities under the Royal Society for Immunology. Prof. Suchkov’s research interests include clinical immunology, predictive and preventive medicine, precision nutrition, and translational biodesign, underpinned by skills in immunobiotechnology, personalized therapy design, clinical trial management, and biomedical innovation. He has authored numerous publications in reputed journals and conferences (IEEE, Scopus-indexed) and actively participates in global professional societies including EPMA, ISPM, PMC, ACS, AHA, ARVO, ISER, and AMEE. Recognized for his leadership and contributions to medical education and clinical practice, he has received multiple honors and holds key advisory roles in international research organizations. Prof. Suchkov’s exceptional expertise, global collaborations, and mentorship capacity position him to advance personalized medicine and immunology research worldwide, foster innovation, and continue contributing to healthcare and scientific communities at the highest level, making him a highly deserving candidate for recognition and awards in his field. 989 Citations | 87 Documents | 12 h-index.

Profiles: Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Suchkov, S. V., Revishvili, A. S., Charchyan, E. R., & Belov, Y. V. (2025). Towards highly precise treatment and rehabilitation in practice of modern cardiologist, cardiac surgeon and cardiac rehabilitation professional.

  2. Suchkov, S. V., Charchyan, E. R., Polyakova, V. N., & Belov, Y. V. (2025). On the path to personalized cardiology: prospects of precise assessment of cardiovascular risks and predictive-prognostic diagnostics.

  3. Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Human Health, Environmental Comfort and Well-Being. Part 2. Ecological Comfort as a New and Strategic Factor in the Protection of Modern Human Health.

  4. Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Human Health, Environmental Comfort and Well-Being. Part 1. Engineering and Design Resources of the Bioindustry on the Way to Safe Competition with the Resources of Natural Biocenoses and Health-Saving Systems.

  5. Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Health, Environmental Comfort and Wellbeing through the Integration of Natural and Engineering-Design Bioresources: At the Junction of Pharmaco- and Nutriodesign to the Bioindustry of Tomorrow.

Mahnaz Ghaebi | Immunology | Best Researcher Award

Published on by Global Scholar Awards

Ms. Mahnaz Ghaebi | Immunology | Best Researcher Award

Prospective PhD Student | Zanjan University of Medical Sciences | Iran

Dr. Mahnaz Ghaebi is a medical immunologist and researcher with strong expertise in regenerative medicine, nanotechnology, immunoengineering, biosensors, micro/nanofluidics, and biomaterials. She earned her B.Sc. in Biology from Zanjan University in 2012, graduating as valedictorian and ranked first in her cohort, followed by an M.Sc. in Medical Immunology from Tabriz University of Medical Sciences in 2018, where she completed her thesis on the frequency and epigenetic factors of Treg, Th17, and exhausted T cells in recurrent implantation failure patients. She has enriched her academic training through a Research Internship Course in Pharmaceutical Bioengineering in 2024, covering stem cell design, protein/enzyme engineering, microbial bioengineering, and vaccine design. Professionally, Dr. Ghaebi has served as a Research Assistant at Zanjan University of Medical Sciences (2023–2024), Laboratory Technician during the COVID-19 pandemic, Teaching Assistant guiding students in immunological protocols, and Research Assistant at Tabriz University of Medical Sciences, where she gained hands-on expertise in molecular and cellular biology techniques, flow cytometry, ELISA, and quantitative PCR. Her research interests bridge basic and applied biomedical sciences, with skills extending to bioinformatics, vaccine design, protein modeling, transcriptomic analysis, and computational tools such as R, Python, and Chimera. She has co-authored a book chapter in Springer’s Handbook of Cancer and Immunology and published in reputed journals including Biomedicine & Pharmacotherapy, while also serving as a peer reviewer for international journals such as Survey of Ophthalmology, International Journal of Rheumatic Diseases, and GeroScience. Dr. Ghaebi’s dedication has been recognized with multiple honors, including academic excellence awards, ranking among the top 30 in Iran’s National Entrance Exam for M.Sc., and receiving letters of appreciation for her volunteer leadership during the COVID-19 crisis. Her scholarly contributions reflect growing international recognition, with 1,032 citations by 918 documents, 20 publications, and an h-index of 16.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

  1. Valizadeh, H., Abdolmohammadi-Vahid, S., Danshina, S., Gencer, M. Z., … & Ghaebi, M. (2020). Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients. International Immunopharmacology, 89, 107088. Cited by: 306

  2. Ghaebi, M., Nouri, M., Ghasemzadeh, A., Farzadi, L., Jadidi-Niaragh, F., Ahmadi, M., … & Yousefi, M. (2017). Immune regulatory network in successful pregnancy and reproductive failures. Biomedicine & Pharmacotherapy, 88, 61–73. Cited by: 173

  3. Tahmasebi, S., Qasim, M. T., Krivenkova, M. V., Zekiy, A. O., Thangavelu, L., … & Ghaebi, M. (2021). The effects of oxygen–ozone therapy on regulatory T‐cell responses in multiple sclerosis patients. Cell Biology International, 45(7), 1498–1509. Cited by: 170

  4. Ahmadi, M., Abdolmohammadi-Vahid, S., Ghaebi, M., Aghebati-Maleki, L., Afkham, A., Danaii, S., … & Yousefi, M. (2017). Effect of intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL). Biomedicine & Pharmacotherapy, 92, 1095–1102. Cited by: 103

  5. Ghaebi, M., Osali, A., Valizadeh, H., Roshangar, L., & Ahmadi, M. (2020). Vaccine development and therapeutic design for 2019‐nCoV/SARS‐CoV‐2: Challenges and chances. Journal of Cellular Physiology, 235(12), 9098–9109. Cited by: 86

Mehdi Yousefi | Immunology and Microbiology | Best Researcher Award

Published on by Global Scholar Awards

Prof. Mehdi Yousefi | Immunology and Microbiology | Best Researcher Award

Professsor at Tabriz University of Medical Sciences, Iran

Prof. Mehdi Yousefi, Associate Professor of Immunology at Tabriz University of Medical Sciences, is a distinguished researcher with an exceptional track record in immunology, reproductive immunology, autoimmune diseases, and cancer immunotherapy. With over a decade of academic and research experience, Prof. Yousefi has published extensively in high-impact journals, earning a Scopus H-index of 58 and a Google Scholar H-index of 71, placing him among the top 1% of highly cited researchers globally. His innovative contributions include several patents on human antibody fragments and advanced biomedical tools, reflecting his strong focus on translational research. Prof. Yousefi has been recognized multiple times as a Top Researcher by Tabriz University of Medical Sciences and has received the prestigious national Razi Award. Through his leadership, collaborative research, and commitment to advancing immunological science, Prof. Yousefi has made significant contributions to both basic and applied biomedical research, enhancing the scientific community’s understanding of immune-related diseases.

Professional Profile 

Education

Prof. Mehdi Yousefi has a strong and distinguished educational background in medical sciences, particularly in immunology. He earned his Bachelor’s degree (B.Sc.) in Medical Laboratory Technology from Tehran University of Medical Sciences in 2004, where he demonstrated academic excellence. He continued his studies at the same university, completing his Master’s degree (M.Sc.) in Immunology in 2007, where he ranked first in the national entrance exam for the program. Building on his passion for immunological research, Prof. Yousefi pursued a PhD in Immunology, also at Tehran University of Medical Sciences, and graduated in 2013 with the highest possible score (20 out of 20). His PhD research focused on humoral immune responses against tetanus toxin at the single-cell level, showcasing his expertise in immunological techniques and innovative approaches to studying immune mechanisms. His consistent academic excellence, top rankings, and commitment to scientific research laid a strong foundation for his successful career in immunology and medical sciences.

Professional Experience

Prof. Mehdi Yousefi has built an impressive professional career rooted in both academic excellence and cutting-edge research. Since 2013, he has served as an academic and research member at the Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, where he currently holds the position of Associate Professor of Immunology. His professional focus spans a wide range of areas, including reproductive immunology, autoimmune diseases, rheumatic disorders, and cancer immunotherapy. Prof. Yousefi has played a pivotal role in mentoring students, leading collaborative research projects, and contributing to the development of advanced immunological diagnostics and therapies. His innovative work has resulted in numerous patents, particularly in the field of antibody fragment development and cancer targeting, demonstrating his ability to bridge fundamental science with clinical applications. Through his leadership, prolific publications, and active participation in the scientific community, Prof. Yousefi has established himself as a respected and influential figure in immunology research.

Research Interest

Prof. Mehdi Yousefi’s research interests focus on understanding the complex mechanisms of the immune system and its role in health and disease. His primary areas of interest include reproductive immunology, where he investigates the immune system’s involvement in pregnancy complications and maternal-fetal tolerance. He also conducts extensive research on autoimmune diseases and rheumatic disorders, aiming to uncover the immunopathological mechanisms driving these conditions to develop more targeted therapies. In addition, Prof. Yousefi has a strong focus on cancer immunotherapy, particularly the development of novel antibody fragments and immunomodulatory approaches for treating cancers such as breast and colorectal cancer. His work also extends to neurosciences, where he explores the immune system’s interactions with the nervous system in neuroinflammatory and neurodegenerative diseases. Through his multidisciplinary approach, combining basic immunology, translational research, and clinical applications, Prof. Yousefi aims to advance immunological knowledge and develop innovative diagnostic and therapeutic strategies for immune-related disorders.

Award and Honor

Prof. Mehdi Yousefi has received numerous prestigious awards and honors, recognizing his outstanding contributions to immunology and biomedical research. He has been repeatedly honored as the Top Researcher at Tabriz University of Medical Sciences in 2014, 2015, 2017, 2020, and 2021, reflecting his consistent excellence in scientific output and impactful research projects. In 2020, he was further recognized at the national level with the prestigious Razi Award, one of the highest honors for medical research in Iran. In 2022, Prof. Yousefi’s global impact was highlighted when he was named among the Top 1% Highly Cited Researchers (ESI), a distinction that underscores the international significance and influence of his publications. These accolades, combined with his numerous patents and his leadership in innovative research projects, demonstrate Prof. Yousefi’s dedication, creativity, and commitment to advancing immunological science, both within Iran and on the global stage.

Research skill

Prof. Mehdi Yousefi possesses a diverse and advanced set of research skills that have enabled him to excel in the fields of immunology, molecular biology, and translational medicine. His expertise includes designing and conducting immunological assays, such as flow cytometry, ELISA, and cell culture techniques, which he applies to study immune responses in conditions ranging from autoimmune diseases to cancer immunotherapy. He has extensive experience in monoclonal antibody development, including phage display technology for the generation of scFv antibody fragments, which has led to several patents. Prof. Yousefi is also skilled in molecular techniques, such as PCR, gene cloning, and gene expression analysis, which he applies to study immune signaling pathways and immune cell interactions. His collaborative approach, combined with strong project management and scientific writing skills, has resulted in numerous high-impact publications and successful research collaborations, making him a well-rounded and innovative researcher in the field of immunology.

Conclusion

His exceptional publication record, high citation impact, consistent institutional and national awards, and innovative patented research make him a top candidate. His breadth of expertise, from immunology to translational medicine, and his proven track record of impactful research across various fields position him strongly for this recognition

Publications Top Noted

  • The effect of vitamin D supplementation and vaginal probiotics on fertility in women with recurrent implantation failure: A randomized clinical trial
    Authors: Badihi E., Sharifi P., Kamrani A., Aghebati-Maleki L., Yousefi M.
    Journal: Human Immunology
    Year: 2025
    Citations: 0

  • Impact of lymphocyte immunotherapy (LIT) on fertility rates in recurrent pregnancy loss (RPL) women with antinuclear antibodies: A randomized clinical trial
    Authors: Dashti M., Kamrani A., Shahir-Khajeh Z., Mehdizadeh A., Yousefi M.
    Journal: Journal of Reproductive Immunology
    Year: 2025
    Citations: 0

  • Intradermal lymphocyte therapy: A promising treatment for recurrent pregnancy loss in patients without anti-TPO antibodies
    Authors: Ebrahimi R., Asghari K.M., Alamdary S.J., Hojjat-Farsangi M., Yousefi M.
    Journal: Human Immunology
    Year: 2025
    Citations: 0

  • The role of probiotics in restoring the Th1 to Th2 ratio in women experiencing recurrent implantation failure; a double-blind randomized clinical trial
    Authors: Kamrani A., Asghari K.M., Zafarani Y., Zolfaghari M.A., Yousefi M.
    Journal: Human Immunology
    Year: 2025
    Citations: 0

  • Investigating the effect of echinacea extraction syrup on the outcomes of lower respiratory infections in patients with COVID-19: a randomized clinical trial study
    Authors: Kheirandish E., Mahdizadeh M., Mahdizadeh M., Yousefi M., Shojaee S.S.R.
    Journal: Virology Journal
    Year: 2024
    Citations: 0

  • Cyclosporine and fedratinib combination therapy via modulating Th17/Treg balance in Rat model of membranous glomerulonephritis
    Authors: Ghassabi A., Hosseini M., Abdoli Goungormaz H., Etemadi J., Yousefi M.
    Journal: Biochemistry and Biophysics Reports
    Year: 2024
    Citations: 0

  • The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha
    Authors: Sadeghi M., Moslehi A., Kheiry H., Movassaghpuor A.A., Niaragh F.J.
    Journal: Cancer Cell International
    Year: 2024
    Citations: 2

  • Evaluation of changes in exhausted T lymphocytes and miRNAs expression in the different trimesters of pregnancy in pregnant women
    Authors: Shekarchi A.A., Hosseini L., Kamrani A., Ahmadian Heris J., Yousefi M.
    Journal: Molecular Biology Reports
    Year: 2024
    Citations: 0

  • Revolutionized attitude toward recurrent pregnancy loss and recurrent implantation failure based on precision regenerative medicine
    Authors: Asghari K.M., Novinbahador T., Mehdizadeh A., Zolfaghari M.A., Yousefi M.
    Journal: Heliyon
    Year: 2024
    Citations: 0

  • Analysis of Th17 cell population and expression of microRNA and factors related to Th17 in patients with premature ovarian failure
    Authors: Nouri N., Aghebati-Maleki L., Zangbar M.S.S., Chakari-Khiavi F., Yousefi M.
    Journal: Journal of Reproductive Immunology
    Year: 2024
    Citations: 2

Kota Ramana | Immunology and Microbiology | Best Researcher Award

Published on by Global Scholar Awards

Dr. Kota Ramana | Immunology and Microbiology | Best Researcher Award

Professor at Noorda College of Osteopathic Medicine, United States

Dr. Kota V. Ramana is a Professor in the Department of Biomedical Sciences at Noorda College of Osteopathic Medicine, Provo, UT, USA. He specializes in cellular metabolism, oxidative stress, and inflammation, focusing on the role of aldo-keto reductases in inflammatory pathways. His research aims to understand how cellular metabolites regulate inflammatory responses in various diseases such as diabetes, sepsis, uveitis, asthma, and cancer. Dr. Ramana employs diverse genetic, biochemical, and cell biological techniques to explore the underlying mechanisms of inflammation and develop therapeutic strategies. He has made significant contributions to the understanding of oxidative stress signaling, cell death pathways, and polyol pathway enzymes in inflammatory conditions, with numerous publications in prestigious journals.

Professional Profile 

Education

Dr. Kota V. Ramana holds a Ph.D. in Biochemistry from the Postgraduate Institute of Medical Education and Research in India. His academic foundation laid the groundwork for his research into cellular metabolism and oxidative stress. This rigorous training has enabled him to delve into the biochemical pathways involved in inflammatory diseases, equipping him with a deep understanding of the complex biological systems at play. His educational background continues to shape his approach to studying inflammation and metabolic regulation in disease contexts, forming the basis for his current investigations and innovations in biomedical research.

Professional Experience

Dr. Kota V. Ramana currently serves as a Professor at Noorda College of Osteopathic Medicine, where he leads research on cellular metabolism and inflammation. Over the years, he has gained substantial experience in various aspects of biochemistry, including cell biology and genetic analysis. His work spans multiple inflammatory diseases, aiming to develop novel therapeutic approaches. Additionally, he has contributed to numerous journal articles on oxidative stress, cell signaling, and the role of enzymes in diseases. His academic and research roles have positioned him as a leader in his field, fostering collaborations and advancing scientific understanding of inflammation-related pathologies.

Research Interest

Dr. Kota V. Ramana’s research interests are primarily focused on understanding the molecular mechanisms that govern cellular metabolism, oxidative stress, and inflammation. His work aims to explore the role of aldo-keto reductases in the regulation of inflammatory pathways. He is particularly interested in how cellular metabolites influence signal transduction, cell death, and survival during inflammatory responses. His research addresses a wide range of inflammatory diseases, including diabetes, sepsis, uveitis, asthma, and cancer. By using genetic, biochemical, and cell biological techniques, Dr. Ramana seeks to develop therapeutic strategies that target oxidative stress and metabolic disturbances associated with these pathologies. His interdisciplinary approach to understanding cellular processes at the molecular level holds promise for advancing treatments for inflammatory and metabolic disorders.

Awards and Honors

Dr. Kota V. Ramana has earned recognition for his significant contributions to biomedical research, particularly in the areas of inflammation, oxidative stress, and cellular metabolism. Although specific awards and honors are not detailed, his academic achievements include numerous publications in prestigious peer-reviewed journals, such as the International Journal of Molecular Sciences, Current Molecular Medicine, and Future Medicinal Chemistry. These accolades highlight his excellence in research and his role as a thought leader in his field. His continued efforts to innovate therapeutic strategies for inflammation-related diseases demonstrate his commitment to advancing medical science and improving patient outcomes. Dr. Ramana’s reputation for high-quality research has led to collaborations with leading experts, further solidifying his position as a prominent figure in biochemistry and biomedical sciences.

Publications Top Noted

  1. Therapeutic Significance of NLRP3 Inflammasome in Cancer: Friend or Foe?
    • Authors: Jalali, A.M., Mitchell, K.J., Pompoco, C., Tran, S., Ramana, K.V.
    • Year: 2024
    • Citations: 0
  2. Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review
    • Authors: Plowman, T.J., Christensen, H., Aiges, M., Shah, M.H., Ramana, K.V.
    • Year: 2024
    • Citations: 5
  3. Significance of Vitamin Supplementation in Reducing the Severity of COVID-19
    • Authors: Aiges, M., Ramana, K.V.
    • Year: 2024
    • Citations: 0
  4. Role of Innate Immune and Inflammatory Responses in the Development of Secondary Diabetic Complications
    • Authors: Plowman, T.J., Shah, M.H., Fernandez, E., Aiges, M., Ramana, K.V.
    • Year: 2023
    • Citations: 7
  5. Therapeutic Potential of Vitamin B1 Derivative Benfotiamine from Diabetes to COVID-19
    • Authors: Allowitz, K.V., Yoo, J.J., Taylor, J.R., Harames, K., Ramana, K.V.
    • Year: 2022
    • Citations: 2
  6. Aldose Reductase Regulates Doxorubicin-Induced Immune and Inflammatory Responses by Activating Mitochondrial Biogenesis
    • Authors: Sonowal, H., Saxena, A., Qiu, S., Srivastava, S., Ramana, K.V.
    • Year: 2021
    • Citations: 13
  7. Development of Aldose Reductase Inhibitors for the Treatment of Inflammatory Disorders and Cancer: Current Drug Design Strategies and Future Directions
    • Authors: Sonowal, H., Ramana, K.V.
    • Year: 2021
    • Citations: 17
  8. 2′-Hydroxyflavanone Prevents LPS-Induced Inflammatory Response and Cytotoxicity in Murine Macrophages
    • Authors: Sonowal, H., Ramana, K.V.
    • Year: 2020
    • Citations: 8
  9. Didymin by Suppressing NF-κB Activation Prevents VEGF-Induced Angiogenesis in Vitro and In Vivo
    • Authors: Shukla, K., Sonowal, H., Saxena, A., Ramana, K.V.
    • Year: 2019
    • Citations: 20
  10. Erratum: Expression of Concern: Aldose Reductase Mediates the Lipopolysaccharide-Induced Release of Inflammatory Mediators in RAW264.7 Murine Macrophages
  • Authors: Ramana, K.V., Fadl, A.A., Tammali, R., Chopra, A.K., Srivastava, S.K.
  • Year: 2019
  • Citations: 0

Jean-nicolas boursiquot | Immunology | Best Researcher Award

Published on by Global Scholar Awards

🌟Dr. Jean-nicolas boursiquot, Immunology, Best Researcher Award 🏆

  •  Doctorate at CHU de Quebec, Canada
 

Jean-Nicolas Boursiquot is a highly qualified medical professional specializing in allergy and clinical immunology. With a comprehensive educational background and extensive research experience, Boursiquot has made significant contributions to the field through publications, presentations, and teaching activities. His dedication to advancing medical knowledge and patient care is evident in his multifaceted professional journey, marked by numerous affiliations, academic commitments, and media engagements. Boursiquot’s expertise encompasses a wide range of topics within allergy and immunology, making him a respected figure in both academic and clinical settings.

Author Metrics:

Scopus Profile

Boursiquot’s author metrics reflect a prolific and impactful academic career, with a substantial number of publications in peer-reviewed journals, presentations at scientific conferences, and media engagements.

  • Citations: 385 citations by 385 documents
  • Documents: 9
  • h-index: 5

Education:

  • Ph.D. in Medicine (M.D.), Laval University, Quebec, Canada, 1999-2004
  • Intensive ESL (English as Second Language) Training, University of Manitoba, Winnipeg, Canada, 1999
  • International Baccalaureate (Pure Sciences), Small Seminary of Quebec, Quebec, Canada, 1997-1999

Research Focus:

Boursiquot’s research focuses primarily on allergy and clinical immunology, with particular interests in immunodeficiencies, allergic rhinitis, asthma, drug allergies, and angioedema. He has conducted studies on various aspects of these conditions, contributing to advancements in diagnosis, treatment, and understanding of underlying mechanisms.

Professional Journey:

Boursiquot’s professional journey spans diverse roles in academia, clinical practice, research, and education:

  • Clinical Allergist and Immunologist at CSSS DES ILES and CSSS DE LAC-SAINT-JEAN-EST
  • Clinical Professor and Educational Ambassador at Laval University
  • Member of various professional committees and boards, including the Canadian Society of Allergy and Clinical Immunology (CSACI) and the Association of Allergists and Immunologists of Quebec (AAIQ)
  • Active involvement in medical education and training, including teaching medical students, residents, and clinicians

Honors & Awards:

  • Recipient of the CMDP of CHUQ and CHUQ-CMDP Foundation Award in 2010
  • Awarded the Humanism Prize in 1997 by the Small Seminary of Quebec

Research Timeline:

1999-2004: Pursued Ph.D. in Medicine at Laval University, Quebec, Canada

2007-2009: Completed Residency in Allergy and Clinical Immunology at McGill University, Montreal, Canada

2010: Conducted Research Fellowship at Pr Éric Oksenhendler Service, St-Louis Hospital, Paris, France

2013-present: Actively engaged in clinical practice, research, teaching, and professional development, making significant contributions to the field of allergy and clinical immunology.

Publications Noted & Contributions:

Boursiquot has made significant contributions to the medical literature through published articles, scientific posters, and presentations at conferences. His research has been focused on topics such as immunodeficiencies, allergic reactions, and treatment strategies. He has also engaged with the media to raise awareness and educate the public about allergies and related conditions.

Safety of Direct Drug Provocation for the Evaluation of Penicillin Allergy in Low-Risk Adults

  • Authors: Brillant-Marquis, F., Proulx, É., Ratnarajah, K., De Serres, G., Drolet, J.-P., Boursiquot, J.-N.
  • Journal: Journal of Allergy and Clinical Immunology: In Practice, 2024, 12(2), pp. 451–457.e2
  • Abstract: [Not available]
  • Citations: 1
  • Note: Open access

A Patient Charter for Chronic Urticaria

  • Authors: Maurer, M., Albuquerque, M., Boursiquot, J.-N., Nigen, S., Winders, T.
  • Journal: Advances in Therapy, 2024, 41(1), pp. 14–33
  • Abstract: [Not available]
  • Citations: 0
  • Review: Open access

Bradykinin-induced angioedema in the emergency department

  • Authors: Hébert, J., Boursiquot, J.-N., Chapdelaine, H., Lepeshkina, O., Vincent, M.
  • Journal: International Journal of Emergency Medicine, 2022, 15(1), 15
  • Abstract: [Not available]
  • Citations: 2
  • Erratum: Open access

Erratum: The International/Canadian Hereditary Angioedema Guideline

  • Authors: Betschel, S., Badiou, J., Binkley, K., Stark, D., Tsai, E.
  • Journal: Allergy, Asthma and Clinical Immunology, 2020, 16(1), 16
  • Abstract: [Not available]
  • Citations: 1
  • Erratum: Open access

Patient and physician perceptions of seasonal allergic rhinitis and allergen immunotherapy: A parallel physician-patient survey

  • Authors: Ellis, A.K., Boursiquot, J., Carr, S., Graham, F., Masse, M.-S.
  • Journal: Allergy, Asthma and Clinical Immunology, 2020, 16(1), 15
  • Abstract: [Not available]
  • Citations: 8